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ABSTRACT 
This commentary review collates and evaluates current review and meta-analysis 
evidence on the association between exercise and depression. Collectively this 
evidence demonstrates a clear and robust effect of depressive symptom reduction as 
a result of exercise, and this effect is shown to be particularly stronger in populations 
with greater severity of depressive symptoms. Examination of potential mechanisms to 
explain this effect reveals factors at biological (e.g. neuroendocrine, neurotrophic, 
oxidative, and cortical pathways), psychological (e.g. self-efficacy, mastery, cognitive 
distraction), and social levels (e.g. reduced social isolation, social support). 
Furthermore, there appear to be several additional indirect effects (e.g. improved 
physical wellbeing, reductions in comorbidity) that further contribute to reduced 
depression. Taken together the evidence shows exercise can reduce depressive 
symptoms, and plausible mechanisms exist to explain this effect. However, whilst 
efficacy is demonstrated, this commentary review also highlights potential issues for 
implementation within clinical practice. The evidence suggests that whilst exercise may 
be a viable treatment option compared to no treatment, there is yet no evidence of 
superiority in comparison to traditional treatment pathways. This raises questions on 
implementation due to the notable association of treatment drop-out and non-
adherence within populations with depression. To address this issue a number of 
relevant strategies are discussed in relation to interventions that use exercise. 
EXERCISE AND HEALTH 
Physical activity and exercise (exercise, i.e. planned, structured physical activity to 
improve physical health; [1]) have benefits on a person’s health. It is well accepted, 
via robust research spanning many decades, that being physically active is associated 
with positive effects in a range of bodily systems including circulatory, respiratory, 
endocrine, musculoskeletal, digestive, nervous, immune and lymphatic system [2,3]. 
Importantly being physically active and participating in exercise has been shown to 
be protective against many major diseases associated with these bodily systems (e.g. 
stroke, chronic obstructive pulmonary disease, musculoskeletal pain, type 2 diabetes, 
cancers), and can also facilitate recovery (or halt progression) in many of these 
diseases [3,4]. There is global recognition of these health benefits; the Lancet Physical 
Activity Series stated that insufficient physical activity is a leading cause of premature 
mortality, with the World Health Organisation planning global action to tackle this 
problem [5,6]. 
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EXERCISE AND DEPRESSION 
Evidence also suggests that physical exercise can confer 
benefits beyond biological systems and has positive effects on 
mental health [4]. Depression has featured as a particular area 
of research focus in this regard [7,8]. Depression is 
conceptualized by the presence of symptoms related to low 
mood and negative self-appraisal, low levels of energy and 
fatigue, sleep disturbance, appetite changes, behavioural 
changes (apathy, agitation), and thoughts of/or actual self-
harm [9]. A core feature of depression (as opposed to feeling 
“down” from time to time) is symptom persistence, and in terms 
of clinical depression (e.g. Major Depressive Disorder, MDD) 
there is a significant impact on a person’s ability to function at 
work and at home, and some form of intervention is required 
[9,10]. Depressive symptoms are common in society, with 
population prevalence estimates between 10% to 15%, with 
MDD population prevalence estimates at 4% to 8% [11,12]. 
Treatments most often involve pharmacological (e.g. anti-
depressant medication) and/or psychological (e.g. Cognitive 
Behavioural Therapy; CBT) approaches [13]. Evaluation of 
current treatments suggest only moderate efficacy, and the 
search is on for alternative treatment options to reduce adverse 
events (mainly pharmacological dependency) and improve 
treatment adherence [13,14]. 
In line with the search for alternative treatments for depression 
is an accumulating body of evidence assessing whether 
exercise is a suitable option. Early research in this area 
observed that neurobiological changes as a result of exercise 
were active within the regions and systems associated with 
depression, notably affecting neuroendocrine, neurotrophic, 
inflammatory, oxidative regulation and cortical brain areas [7]. 
A number of clinical trials and studies have since been 
conducted to test whether exercise can reduce depressive 
symptoms, with collective evidence presented in a number of 
systematic review and meta-analysis publications. A Cochrane 
review [15] of 28 trials (25 included within their meta-analysis) 
reported an overall large effect size (standardized mean 
difference, SMD 0.82) favoring exercise compared with control 
arms, though this effect size was significantly lessened (SMD 
0.62) when the authors applied more stringent criteria (e.g. 
only including studies that employed blinding). In addition, no 
differences were reported when comparing exercise to other 
treatment arms (i.e. not superior to anti-depressants or CBT). 
However, the authors of this Cochrane review did note 
significant population heterogeneity within their included 
studies; in particular an issue of case mix (populations including 
both those with mild and more severe forms of depression), 
highlighting a need for further research to assess potential 
subgroup differences. A later meta meta-analysis [16], 
considering the effects of physical activity in non-clinical 
populations of those with depression or anxiety, reported on 
two meta-analyses specifically on depression (92 studies, n = 
4310). Results of this meta meta-analysis show an overall 
medium effect size (SMD 0.50), again supporting the 
hypothesis that exercise can reduce depressive symptoms. A 
further meta-analysis [8] aimed to overcome some of the 
earlier bias issues reported by earlier meta-analyses (e.g. 
Cochrane review by Mead et al. [15]). This new review by 
Schuchb et al. [8] reported an overall sizable large effect size 
(SMD 1.11) when controlling for biases and heterogeneity. In 
further subgroup analysis that separated depressive sub-
populations (non-clinical, clinical), they reported a larger effect 
size of exercise on symptom reduction in those with MDD (SMD 
1.14). Interestingly, this effect was increased in those with a 
greater severity of symptoms, in those who were older in age, 
and in those with increased comorbidity. Overall the meta-
analysis by Schuchb et al. [8] report a sizable and clinically 
meaningful reduction in depressive symptoms as a result of 
exercise; equivalent to -5 points on the Hamilton Rating Scale 
for Depression ([17], or -6 points on the Beck Depression 
Inventory [18]. 
Taken collectively the evidence from these meta-analyses 
clearly demonstrate the benefit of exercise on the reduction of 
depressive symptoms, and this effect appears stronger (and 
clinically useful; [19]) in those with clinical level depression, with 
further additional effect in those with comorbidity (thought to 
be attributed to the effect of exercise on other health 
conditions leading to indirect influences). This accumulating 
evidence has initiated the promotion of psychical health and 
exercise within depression treatment guidelines, for example 
National Institute of Clinical Excellence (NICE) guidelines in the 
UK [20], and recent guidance for the European Psychiatric 
Association [21]. 
Anxiety And Depression Journal 
 03 
Does Exercise Reduce Depressive Symptoms? Commentary Review on Efficacy, Mechanisms and Implementation. Anxiety And 
Depression Journal. 2020; 3(1):121. 
MECHANISMS OF EFFECT 
The mechanisms of the effect of exercise on depression are 
complex and include potential bio-psychosocial pathways [3]. 
The following section will outline the evidence of potential 
mechanisms of effect for these pathways. 
Biological pathways 
A recent systematic review of studies on those with MDD [7] 
examined evidence of biomarker responses to exercise across 
five current biological hypotheses (neuroendocrine, 
neurotrophic, inflammatory, oxidative and cortical volume).A 
brief outline of these findings will be presented here, a more 
in-depth discussion of these results can be found within the 
original review [7]. On neuroendocrine effects, the authors 
examined two studies that had measured cortisol presence (a 
marker of elevated stress levels brought about by activation of 
the hypothalamic-pituitary-adrenocortical axis, which is the 
body’s central stress response system; [22]) and report no 
evidence of change. However, they did find evidence in one 
study of another marker of elevated stress (copeptin; [23]), 
which was shown to increase in the acute phase (i.e. just after 
exercise) but then decrease in the long term (in the weeks 
following exercise). The review also reported on two studies 
that considered changes in prolactin (proxy indicator of 
serotonergic secretion, a process known to be robustly 
associated with depression and involved in the synthesis of anti-
depressive medication; [24]) which found no change as a result 
of exercise, but did report on two studies that found increases 
in growth hormone. Such increase in growth hormones are 
thought to stimulate neurogenesis, understood to be important 
in increasing overall neuroplasticity, and may play an 
important role in the optimal synthesis of anti-depressant 
medication [25]. For neurotrophic effect, the authors report on 
two studies that had found increases in Nerve Growth Factors 
(NGF), and NGF has been shown to be associated with 
increased neuronal plasticity, again thought to be an important 
moderator of anti-depressant efficacy [26]. The review also 
reported on evidence of Brain Derived Neurotrophic Factor 
(BDNF), which has been shown to be depleted in those with 
depression, but elevated after exercise in animal models [27]. 
Results from the review show no evidence of significant change 
in BDNF from serum sampling, however the authors do comment 
that these particular studies were confounded by patient 
heterogeneity, and presence of anti-depressant pharmacology 
which can disrupt BDNF levels. For inflammatory markers 
(thought to mediate the harmful effects of depression; [28]), the 
authors report no significant change in pro-inflammatory 
cytokine levels as a result of exercise. Evidence of oxidative 
change (oxidative stress shown to be associated with 
depression, more so in those with long term depression; [29]) 
was found in one study within the acute phase and it is thought 
that stimulation of oxidative stress from exercise would 
stimulate greater levels of neuronal repair. Finally, the review 
reports on cortical volume within the hippocampus (shown to be 
reduced in those with MDD; [30]), the authors report on a 
single study that found increased hippocampal cortical volume 
over time. Overall the evidence demonstrates that biological 
pathways may give some explanation to the beneficial effects 
of exercise on depression, in particular neuroendocrine, 
neurotrophic, oxidative and cortical pathways. However, many 
of the individual findings outlined within the Schucha et al. [7] 
review are based on a small number of studies, and more 
evidence is required before robust conclusions can be drawn. 
Psychological and social pathways 
A recent meta review [21] and editorial commentary [31] both 
commented that the effects of exercise on those with 
depression are likely to be multidimensional, with important 
mediators (explaining the effect) and moderators (changing the 
effect) at a psychosocial level. Examining evidence of 
psychosocial effects as reported within the meta-analysis 
papers described above [7,8,15,16] and this more recent 
review and commentary ([21,31] respectively), show consensus 
on the effects of exercise across a number of psychological 
and social factors. One key recurrent theme that emerges from 
this evidence is the concepts of mastery and self-efficacy 
(feelings of confidence in activities and duties, and feelings of 
self-worth, both shown to be greatly reduced in those with 
depression; [12,32]). These constructs were shown to 
significantly increase as a result of participation in exercise, 
thought to give the patient a sense of mastery over a new skill 
and increase self-confidence. Evidence also shows that exercise 
was associated with a reduction in fatigue levels and improved 
sleep hygiene, both of which are a core feature of depressive 
symptoms [33,34]. Another beneficial psychological feature 
thought to play an important role was “cognitive distraction”, 
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the actual act of exercise reduced time for participants to focus 
on negative thoughts (negative attentional and interpretational 
biases are common in depression; [35]) and supplanted 
positive thoughts associated with achievement and mastery. 
Furthermore, the evidence showed greater effects of exercise 
on participants who had received ongoing supervision and 
support [8], and this may be as a result of the benefits of 
positive reinforcement from supervising staff (e.g. behavioural 
activation/reinforcement influences; [36]). There is also 
evidence of social factor influences. Evidence showed 
reductions in reported social isolation levels (a key feature of 
depression; [37]). Increases in social support (from other 
participants as well as instructors and clinical staff) were also 
reported; increases in social support has been shown to 
associate with reduction in depressive symptoms [38,39], in 
addition social participation has been shown to influence 
positive social cognitive processes (attributions of others, 
interpretation of others) in those with depression [40]. 
The evidence directly above suggests that exercise can 
influence depressive symptoms via a number psychological and 
social pathways. In addition to these direct effects are wider 
influences as reported in the conclusions of two aforementioned 
reviews [8,21]. These reviews comment on residual effects of 
exercise at a biopsychosocial level, based on the findings that 
clinical improvement was greatest in those with more severe 
depressive symptoms and those who reported greater levels of 
comorbidity. Explanations for this effect are improved overall 
lifestyle factors (better diet, reductions in smoking, additive 
effects of exercise on cardiovascular, respiratory and 
metabolic conditions) leading to increases in general quality of 
life and wellbeing. Overall the evidence suggests a cascade 
effect of exercise that directly influences via multiple 
biopsychosocial pathways directly related to depression, as 
well as evidence of broader indirect influences. 
IMPLEMENTATION 
Whilst the evidence above clearly shows the benefit of 
physical exercise on the reduction of symptoms in those with 
clinical depression, and demonstrates viable pathways to 
explain this effect, there remain some important considerations. 
Many of the reviews and meta-analyses (as outlined above) 
comment on specific issues such as high dropout rates and 
attrition within various intervention trials. Treatment adherence 
is one of the key challenges for the management of depression, 
with patients with depression being more than twice as likely to 
be non-adherent [41]. For example, Stubbs et al [21], in their 
meta review and guideline statement, show the dropout rates 
of 31 exercise based randomized controlled trials for those 
with MDD was between 13% to 21%. This raises particular 
issues for what is arguably a more intrusive intervention (e.g. 
requires personal investment of time and sustained effort) 
compared to standardized pharmacological treatments. A 
recent project that developed a tool kit for exercise 
interventions designed for those with depression has 
recognized these particular issues of non-adherence [42]. They 
recommend consideration of the following for successful 
implementation; literature for patients and clinicians to explain 
the benefits of exercise, training for clinicians on assessment to 
consider appropriate dosage (e.g. due to comorbidity, fatigue, 
depressive severity), addressing low motivation levels in 
patients by providing emotional support and guidance (e.g. 
motivational interviews), continued supervised support during 
exercise, involvement in group activity (increase general social 
support), and the setting of goals with regular ongoing 
progress review. 
CONCLUSION 
It is clear that physical exercise can benefit those who have 
clinical depression. The mechanisms to explain this effect are 
complex and operate at a biopsychosocial level. These 
mechanisms involve factors that directly influence depressive 
symptoms, as well as indirect factors that can have wider 
beneficial effects on general health and lifestyle. The key 
challenge at present is not whether exercise is beneficial, the 
evidence is strong that it is, but more so on how exercise can be 
successfully implemented in a clinical population that is 
associated with low motivation, treatment 
resistance/nonadherence, and relapse. Future pragmatic 
implementation research is now required to investigate these 
issues further in order to increase confidence in considering 
exercise as part of the clinical tool kit. 
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